It has been reported that inflammation takes a central role in pancreatic cancer development, and NF-κB pathway is characterized as a key pathway of inflammation, and frequently dysregulated in pancreatic cancer [21–23]. Here, NFKB1 is linked to familial pancreatic carcinoma.